RxDoctor Payments Data

Jacob Hummel

Physician Assistant · Nanticoke, PANPI 1083370191

Payments from drug & device makers

$4,654in general payments, 2019–2025

Across 130 payments — averaging $35.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$1K
  • Neurocrine Biosciences, Inc.$874
  • Alkermes, Inc.$778
  • Johnson & Johnson$583
  • AbbVie$371
  • Otsuka America Pharmaceutical, Inc.$242
  • plus $670 from 10 others

What the payments were for

  • Food & beverage$4,54398%
  • Education$1112%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,654 in reported general payments places this provider in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate51$144,504
Invega TrinzaPaliperidone Palmitate13$136,725
IngrezzaValbenazine Tosylate11$94,023
Abilify MaintenaAripiprazole30$86,011
FanaptIloperidone14$42,104
VraylarCariprazine Hcl22$31,889
LybalviOlanzapine/Samidorphan Malate14$23,881
Chlorpromazine Hcl39$10,930
Clozapine135$8,502
Fluphenazine Hcl60$3,022
Aripiprazole61$2,829
Olanzapine227$2,727
Thiothixene12$1,496
Perphenazine45$1,343
Celecoxib11$1,282

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Invega Trinza$583$281,22964 claims
Neurocrine Biosciences, Inc.Ingrezza$874$94,02311 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$242$86,01130 claims
Vanda Pharmaceuticals Inc.Fanapt$77$42,10414 claims
AbbVieVraylar$371$31,88922 claims
Alkermes, Inc.Lybalvi$778$23,88114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Nanticoke

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →